Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Vaxjo

23 clinical trials in Vaxjo, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Vaxjo at a glance
23
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

23 trials in Vaxjo

Open in trial search

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Revolution Medicines Inc.

Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Uppsala Universitet

Study of personalized tamoxifen dosing (10mg, 20mg, or 40mg daily) compared to standard dose (20mg) in women with breast cancer to improve treatment continuation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen
  • Sponsor:Karolinska Institutet

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm

Diabetic foot

Recruiting

Study on Sodium Hypochlorite and Polyhexamethylene Biguanide for Healing Diabetic Foot Ulcers in Patients with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg

Study on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Karolinska Institutet

Breast cancer

Recruiting

Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Region Oerebro Laen

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

Ureteric cancer+7

Recruiting

Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Region Oestergoetland

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Vaxjo

What the registry says about research in the country

01 Oncology Studies

Research focusing on innovative treatments for various cancers, including breast cancer, prostate cancer, and melanoma. Studies explore both early-stage and metastatic disease management.

  • Triple-negative breast cancer treatment optimization
  • Immunotherapy duration in melanoma
  • Biomarker-driven prostate cancer therapies

These trials aim to improve treatment outcomes and patient survival rates through targeted therapies and optimized treatment durations.

02 Cardiovascular & Metabolic Research

Studies addressing type 2 diabetes, dyslipidemia, and related conditions. Research includes innovative treatment approaches and comparative effectiveness studies.

  • Diabetes management optimization
  • Acute myocardial infarction treatments
  • Diabetic foot ulcer healing

Investigations focus on improving patient outcomes through novel therapeutic approaches and treatment combinations.

03 Women's Health Initiatives

Comprehensive research in HPV prevention and screening, along with studies in labor induction and women's reproductive health management.

  • Cervical cancer prevention strategies
  • Outpatient labor induction safety
  • HPV vaccination effectiveness

These trials aim to enhance preventive care and improve treatment protocols in women's health.

04 Renal & Urological Studies

Investigations into chronic kidney disease treatments and various urological conditions, including innovative surgical approaches.

  • CKD management strategies
  • Bladder cancer treatments
  • Surgical pain management protocols

Research focuses on improving treatment outcomes and patient quality of life in renal and urological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.